Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin. Pemphigus is ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Principia Biopharma, a private, clinical-stage biopharmaceutical company, today announced a late-breaking oral presentation of interim data from a Phase 2 ...
IN the consideration of vesiculating and bullous eruptions of the oral mucosa, insufficient attention has been given to benign mucous-membrane pemphigus as a distinct clinical entity. Also, in many ...
BOSTON--(BUSINESS WIRE)--Syntimmune, Inc., a clinical-stage biotechnology company developing antibody therapeutics targeting FcRn, today announced positive preliminary results from its Phase 1b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results